Related Experiment Video
Updated: May 31, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
THE INTERACTION BETWEEN ANTITHROMBIN AND ENDOTHELIAL HEPARAN SULFATE MITIGATES PULMONARY THROMBOINFLAMMATION AFTER
Maria Del Pilar Huby Vidaurre1, Ava K Mokhtari, Baron K Osborn
1Department of Surgery, Division of Acute Care Surgery, and the Center for Translational Injury Research, The University of Texas Health Science Center and the McGovern School of Medicine, Houston, Texas.
Trauma and hemorrhagic shock reduce protective heparan sulfate. Blocking antithrombin (AT) interactions with endothelial cells impairs AT
Area of Science:
- Biochemistry
- Immunology
- Physiology
Background:
- Trauma and hemorrhagic shock (T/HS) are linked to multiple organ injuries.
- Antithrombin (AT) exhibits anti-inflammatory and organ-protective effects via interaction with endothelial heparan sulfate (HS).
- A specific 3- O -sulfate modification on HS is crucial for AT's activity.
Purpose of the Study:
- To investigate the impact of T/HS on 3- O -sulfated (3-OS) HS expression.
- To determine if AT-HS interactions are essential for AT's anti-inflammatory properties.
Main Methods:
- Male Sprague-Dawley rats underwent T/HS and resuscitation.
- Pulmonary and plasma HS levels were quantified using liquid chromatography-coupled mass spectrometry.
- Lung injury and inflammatory markers were assessed histologically and biochemically.
- Rats were treated with vehicle or surfen, a HS antagonist, before T/HS and resuscitation with fresh frozen plasma (FFP), lactated Ringer's (LR), or AT-supplemented LR.
Main Results:
- T/HS significantly decreased pulmonary 3-OS HS expression and related sulfotransferase mRNA levels.
- Surfen treatment exacerbated fibrin deposition and inflammatory cell infiltration in FFP-resuscitated rats.
- Blocking AT-HS interactions abrogated FFP's anti-inflammatory effects and worsened lung injury.
- Supplementation with AT during LR resuscitation, combined with surfen, increased lung injury.
Conclusions:
- T/HS markedly reduces pulmonary 3-OS HS expression, which is vital for AT's antithrombotic and anti-inflammatory functions.
- Inhibition of AT-endothelial interactions negates the organ-protective benefits of FFP during T/HS.
- AT's interaction with the endothelium is critical for its anti-inflammatory signaling and organ protection in T/HS.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

